Home
ERAS
ERAS News

Latest Erasca Inc. (ERAS) News on November 15, 2025

3 Promising Penny Stocks With Market Caps As Low As $200M

Simply Wall St.

2 days ago

3 Promising Penny Stocks With Market Caps As Low As $200M

Erasca Reports Third Quarter 2025 Business Updates and Financial Results

GlobeNewswire

3 days ago

Erasca Reports Third Quarter 2025 Business Updates and Financial Results

Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015

GlobeNewswire

9 days ago

Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015

Erasca to Present at Upcoming Conferences in November

GlobeNewswire

11 days ago

Erasca to Present at Upcoming Conferences in November

MT Newswires

a month ago

Stifel Nicolaus Initiates Coverage on Erasca With Buy Rating, $4 Price Target

Discovering Potential: IZEA Worldwide And 2 Other Top Penny Stocks

Simply Wall St.

a month ago

Discovering Potential: IZEA Worldwide And 2 Other Top Penny Stocks

Spotlight On September 2025's Promising Penny Stocks

Simply Wall St.

2 months ago

Spotlight On September 2025's Promising Penny Stocks

MT Newswires

5 months ago

Erasca Receives US FDA Approval of ERAS-4001 Investigational New Drug Application for Solid Tumors

Erasca Announces IND Clearance for Potential First-in-Class and Best-in-Class Pan-KRAS Inhibitor ERAS-4001

GlobeNewswire

5 months ago

Erasca Announces IND Clearance for Potential First-in-Class and Best-in-Class Pan-KRAS Inhibitor ERAS-4001

Discover May 2025's Top Penny Stocks

Simply Wall St.

6 months ago

Discover May 2025's Top Penny Stocks

Erasca to Present at Upcoming Investor Conferences in June

GlobeNewswire

6 months ago

Erasca to Present at Upcoming Investor Conferences in June

Erasca Reports First Quarter 2025 Business Updates and Financial Results

GlobeNewswire

6 months ago

Erasca Reports First Quarter 2025 Business Updates and Financial Results

MT Newswires

6 months ago

Erasca Seeks Partner for Naporafenib to Extend Cash Runway

Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway

GlobeNewswire

6 months ago

Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway

Erasca to Present at the Bank of America Securities Health Care Conference

GlobeNewswire

6 months ago

Erasca to Present at the Bank of America Securities Health Care Conference

Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting

GlobeNewswire

7 months ago

Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting

Is Erasca Inc. (NASDAQ:ERAS) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Insider Monkey

7 months ago

Is Erasca Inc. (NASDAQ:ERAS) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Erasca Slides As Insider Purchases Lose Another US$84k

Simply Wall St.

7 months ago

Erasca Slides As Insider Purchases Lose Another US$84k

MT Newswires

8 months ago

Raymond James Initiates Erasca at Outperform With $5 Price Target

Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting

GlobeNewswire

8 months ago

Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting

Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results

GlobeNewswire

8 months ago

Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results

Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference

GlobeNewswire

10 months ago

Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference

Down -25.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Erasca (ERAS)

Zacks

10 months ago

Down -25.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Erasca (ERAS)

Erasca (NASDAQ:ERAS) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

10 months ago

Erasca (NASDAQ:ERAS) Is In A Good Position To Deliver On Growth Plans

Down -27.17% in 4 Weeks, Here's Why Erasca (ERAS) Looks Ripe for a Turnaround

Zacks

10 months ago

Down -27.17% in 4 Weeks, Here's Why Erasca (ERAS) Looks Ripe for a Turnaround

Down -24.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Erasca (ERAS)

Zacks

10 months ago

Down -24.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Erasca (ERAS)

Down -22.89% in 4 Weeks, Here's Why You Should You Buy the Dip in Erasca (ERAS)

Zacks

10 months ago

Down -22.89% in 4 Weeks, Here's Why You Should You Buy the Dip in Erasca (ERAS)

MT Newswires

10 months ago

BofA Securities Upgrades Erasca to Buy From Neutral, Maintains $5 Price Target

Erasca to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

10 months ago

Erasca to Present at the 43rd Annual J.P. Morgan Healthcare Conference

MT Newswires

a year ago

Jefferies Initiates Erasca at Buy With $6 Price Target

Erasca (ERAS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Zacks

a year ago

Erasca (ERAS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Erasca Reports Third Quarter 2024 Business Updates and Financial Results

GlobeNewswire

a year ago

Erasca Reports Third Quarter 2024 Business Updates and Financial Results

Erasca to Present at Upcoming Investor Conferences

GlobeNewswire

a year ago

Erasca to Present at Upcoming Investor Conferences

Erasca Insiders Added US$1.95m Of Stock To Their Holdings

Simply Wall St.

a year ago

Erasca Insiders Added US$1.95m Of Stock To Their Holdings

Erasca Announces Strong Momentum for Naporafenib and RAS Targeting Franchise

GlobeNewswire

a year ago

Erasca Announces Strong Momentum for Naporafenib and RAS Targeting Franchise

Erasca to Present Preliminary SEACRAFT-1 Phase 1 Data for Naporafenib Plus Trametinib in RAS Q61X Mutant Solid Tumors as Oral Presentation at 36th EORTC-NCI-AACR Symposium

GlobeNewswire

a year ago

Erasca to Present Preliminary SEACRAFT-1 Phase 1 Data for Naporafenib Plus Trametinib in RAS Q61X Mutant Solid Tumors as Oral Presentation at 36th EORTC-NCI-AACR Symposium

Erasca, Inc. (NASDAQ:ERAS) is favoured by institutional owners who hold 61% of the company

Simply Wall St.

a year ago

Erasca, Inc. (NASDAQ:ERAS) is favoured by institutional owners who hold 61% of the company

Erasca to Present at Upcoming Investor Conferences in September

GlobeNewswire

a year ago

Erasca to Present at Upcoming Investor Conferences in September

We're Hopeful That Erasca (NASDAQ:ERAS) Will Use Its Cash Wisely

Simply Wall St.

a year ago

We're Hopeful That Erasca (NASDAQ:ERAS) Will Use Its Cash Wisely

MT Newswires

a year ago

Erasca Q2 Loss Widens; Expects Cash to Fund Operations Until H1 of 2027

Erasca Reports Second Quarter 2024 Business Updates and Financial Results

GlobeNewswire

a year ago

Erasca Reports Second Quarter 2024 Business Updates and Financial Results

Erasca kicks off Phase III trial for naporafenib combo therapy in melanoma

Clinical Trials Arena

a year ago

Erasca kicks off Phase III trial for naporafenib combo therapy in melanoma

Erasca Initiates SEACRAFT-2 Pivotal Phase 3 Trial Evaluating Naporafenib Plus Trametinib in Patients with NRAS-Mutant Melanoma

GlobeNewswire

a year ago

Erasca Initiates SEACRAFT-2 Pivotal Phase 3 Trial Evaluating Naporafenib Plus Trametinib in Patients with NRAS-Mutant Melanoma

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

PR Newswire

a year ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

Enhancing the Power of PTZs: Canon Announces New PTZ Firmware Updates Lending Greater Control and Operability, Including an Auto-Tracking Lite Version on Compatible PTZ Models*

GlobeNewswire

a year ago

Enhancing the Power of PTZs: Canon Announces New PTZ Firmware Updates Lending Greater Control and Operability, Including an Auto-Tracking Lite Version on Compatible PTZ Models*

Business Wire

a year ago

Form 8.3 - Darktrace plc

Business Wire

a year ago

Form 8.3 - International Distribution Services plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Reuters

a year ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

Investor's Business Daily

a year ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

GlobeNewswire

a year ago

Middlefield Canadian Income PCC: Net Asset Value(s)

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

Business Wire

a year ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

Should You Buy Erasca, Inc. (ERAS) After Golden Cross?

Zacks

a year ago

Should You Buy Erasca, Inc. (ERAS) After Golden Cross?

Erasca to Present at Upcoming Investor Conferences in June

GlobeNewswire

a year ago

Erasca to Present at Upcoming Investor Conferences in June

Independent Director of Erasca Picks Up 14% More Stock

Simply Wall St.

a year ago

Independent Director of Erasca Picks Up 14% More Stock

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 05/23/2024

MT Newswires

a year ago

Erasca Closes Oversubscribed Share Offering to Raise $184 Million

Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

a year ago

Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

MT Newswires

a year ago

Erasca Acquires 2 Exclusive Worldwide Licenses for Preclinical RAS Programs

Erasca restructures; Novartis moves to complete MorphoSys deal

BioPharma Dive

a year ago

Erasca restructures; Novartis moves to complete MorphoSys deal

MT Newswires

a year ago

Erasca Prices $160 Million Common Stock Offering

Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise

GlobeNewswire

a year ago

Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise

Erasca Announces Pricing of Underwritten Offering of Common Stock

GlobeNewswire

a year ago

Erasca Announces Pricing of Underwritten Offering of Common Stock

Erasca Reports First Quarter 2024 Business Updates and Financial Results

GlobeNewswire

2 years ago

Erasca Reports First Quarter 2024 Business Updates and Financial Results

Erasca to Present at the Bank of America Health Care Conference

GlobeNewswire

2 years ago

Erasca to Present at the Bank of America Health Care Conference

Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting

GlobeNewswire

2 years ago

Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting

Erasca (ERAS) Upgraded to Strong Buy: What Does It Mean for the Stock?

Zacks

2 years ago

Erasca (ERAS) Upgraded to Strong Buy: What Does It Mean for the Stock?

Institutional investors may adopt severe steps after Erasca, Inc.'s (NASDAQ:ERAS) latest 11% drop adds to a year losses

Simply Wall St.

2 years ago

Institutional investors may adopt severe steps after Erasca, Inc.'s (NASDAQ:ERAS) latest 11% drop adds to a year losses

Erasca, Inc. (NASDAQ:ERAS) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Erasca, Inc. (NASDAQ:ERAS) Q4 2023 Earnings Call Transcript

GuruFocus.com

2 years ago

Erasca Inc (ERAS) Aligns with EPS Projections, Reveals Robust Balance Sheet and Key Clinical ...

Erasca Announces $45 Million Oversubscribed Private Placement Financing

GlobeNewswire

2 years ago

Erasca Announces $45 Million Oversubscribed Private Placement Financing

Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results

GlobeNewswire

2 years ago

Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results

Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials

GlobeNewswire

2 years ago

Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials

Rainbow Realty Group Announces Launch of Fund IV: Capitalizing on a Moment in Time

PR Newswire

2 years ago

Rainbow Realty Group Announces Launch of Fund IV: Capitalizing on a Moment in Time

Erasca to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

GlobeNewswire

2 years ago

Erasca to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Just Four Days Till Kearny Financial Corp. (NASDAQ:KRNY) Will Be Trading Ex-Dividend

Simply Wall St.

2 years ago

Just Four Days Till Kearny Financial Corp. (NASDAQ:KRNY) Will Be Trading Ex-Dividend

Traditional Fast Food Q3 Earnings: Arcos Dorados (NYSE:ARCO) is the Best in the Biz

StockStory

2 years ago

Traditional Fast Food Q3 Earnings: Arcos Dorados (NYSE:ARCO) is the Best in the Biz

Sandy Spring Bancorp, Inc. (NASDAQ:SASR) Q4 2024 Earnings Call Transcript

Insider Monkey

2 years ago

Sandy Spring Bancorp, Inc. (NASDAQ:SASR) Q4 2024 Earnings Call Transcript

Strength Seen in Zuora (ZUO): Can Its 6.1% Jump Turn into More Strength?

Zacks

2 years ago

Strength Seen in Zuora (ZUO): Can Its 6.1% Jump Turn into More Strength?

Frontdoor Donates Carroll Facility to St. Anthony Regional Hospital

Business Wire

2 years ago

Frontdoor Donates Carroll Facility to St. Anthony Regional Hospital

Data Analytics Stocks Q2 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest

StockStory

2 years ago

Data Analytics Stocks Q2 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The Rest

Is GrafTech International Ltd. (NYSE:EAF) Potentially Undervalued?

Simply Wall St.

2 years ago

Is GrafTech International Ltd. (NYSE:EAF) Potentially Undervalued?

Denison Announces $16 Million Contract Award to Wood for Completion of Detailed Design Engineering for Flagship Phoenix Isr Project

CNW Group

2 years ago

Denison Announces $16 Million Contract Award to Wood for Completion of Detailed Design Engineering for Flagship Phoenix Isr Project

Vertical Software Stocks Q3 Earnings: Doximity (NYSE:DOCS) Best of the Bunch

StockStory

2 years ago

Vertical Software Stocks Q3 Earnings: Doximity (NYSE:DOCS) Best of the Bunch

American Home Shield Offering U.S. Military Veterans Steep Discount on Home Warranty Plans

Business Wire

2 years ago

American Home Shield Offering U.S. Military Veterans Steep Discount on Home Warranty Plans

All You Need to Know About Invivyd, Inc. (IVVD) Rating Upgrade to Strong Buy

Zacks

2 years ago

All You Need to Know About Invivyd, Inc. (IVVD) Rating Upgrade to Strong Buy

Household Products Stocks Q3 Highlights: Kimberly-Clark (NYSE:KMB)

StockStory

2 years ago

Household Products Stocks Q3 Highlights: Kimberly-Clark (NYSE:KMB)

Nevro's (NVRO) Preliminary Q4 Revenues Boosted by PDN Sales

Zacks

2 years ago

Nevro's (NVRO) Preliminary Q4 Revenues Boosted by PDN Sales

DoubleDown Interactive to Participate at 26th Annual Needham Growth Conference on January 18

GlobeNewswire

2 years ago

DoubleDown Interactive to Participate at 26th Annual Needham Growth Conference on January 18

The 3 Best Flying Car Stocks to Buy in January 2024

InvestorPlace

2 years ago

The 3 Best Flying Car Stocks to Buy in January 2024

Is Erasca (NASDAQ:ERAS) In A Good Position To Invest In Growth?

Simply Wall St.

2 years ago

Is Erasca (NASDAQ:ERAS) In A Good Position To Invest In Growth?

J&J, Merck and Boston Scientific Go on $6.4 Billion Buying Spree

Bloomberg

2 years ago

J&J, Merck and Boston Scientific Go on $6.4 Billion Buying Spree

OrthoPediatrics Corp. Announces Acquisition of Boston Orthotics & Prosthetics

GlobeNewswire

2 years ago

OrthoPediatrics Corp. Announces Acquisition of Boston Orthotics & Prosthetics

3 Quality Growth Stocks to Buy Under $20 for Multibagger Returns

InvestorPlace

2 years ago

3 Quality Growth Stocks to Buy Under $20 for Multibagger Returns

SI-BONE Inc Director Davis Timothy E JR Sells 9,900 Shares

GuruFocus.com

2 years ago

SI-BONE Inc Director Davis Timothy E JR Sells 9,900 Shares

Best Value Stocks to Buy for January 5th

Zacks

2 years ago

Best Value Stocks to Buy for January 5th

Erasca to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

2 years ago

Erasca to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Invivyd Submits Request for Emergency Use Authorization (EUA) to U.S. FDA for VYD222 for the Pre-exposure Prevention of COVID-19 in Immunocompromised Adults and Adolescents

GlobeNewswire

2 years ago

Invivyd Submits Request for Emergency Use Authorization (EUA) to U.S. FDA for VYD222 for the Pre-exposure Prevention of COVID-19 in Immunocompromised Adults and Adolescents

Meridian Small Cap Growth Fund Trimmed Hudson Technologies (HDSN) as the Share Price Appreciated

Insider Monkey

2 years ago

Meridian Small Cap Growth Fund Trimmed Hudson Technologies (HDSN) as the Share Price Appreciated

Business Wire

2 years ago

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

3 Penny Stocks You’ll Regret Not Buying Soon: December Edition

InvestorPlace

2 years ago

3 Penny Stocks You’ll Regret Not Buying Soon: December Edition

Share on Social Networks: